Author:
Nakamura Hideki,Kawakami Atsushi,Iwamoto Naoki,Ida Hiroaki,Koji Takehiko,Eguchi Katsumi
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry, medical,Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference19 articles.
1. Fox RI (2005) Sjögren’s syndrome. Lancet 366(9482):321–331. doi: 10.1016/S0140-6736(05)66990-5
2. Nakamura H, Kawakami A, Eguchi K (2006) Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren’s syndrome. Transl Res 148:281–288. doi: 10.1016/j.trsl.2006.07.003
3. Pan G, O’Rourke K, Chinnaiyan AM et al (1997) The receptor for the cytotoxic ligand TRAIL. Science 276(5309):111–113. doi: 10.1126/science.276.5309.111
4. Nakamura H, Kawakami A, Ida H, Koji T, Eguchi K (2007) EGF activates PI3 K-Akt and NF-kappaB via distinct pathways in salivary epithelial cells in Sjögren’s syndrome. Rheumatol Int 28:127–136. doi: 10.1007/s00296-007-0411-9
5. Nakamura H, Kawakami A, Ida H, Koji T, Eguchi K (2007) Epidermal growth factor inhibits Fas-mediated apoptosis in salivary epithelial cells of patients with primary Sjögren’s syndrome. Clin Exp Rheumatol 25:831–837
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献